MedTrace Logo

Efficacy of Chinese Herbal Medicine Qing Re Huo Xue in Patients With Rheumatoid Arthritis

NCT04170504 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 204

Last updated 2024-09-23

No results posted yet for this study

Summary

This study is a multicenter, randomized, double-blinded, placebo-controlled trial with two parallel arms. The aim of the study is to evaluate whether Chinese herbal medicine Qing Re Huo Xue (QRHX) combined with methotrexate (MTX) might be better than Qing Re Huo Xue placebo combined with MTX for patients with active rheumatoid arthritis (RA).

Conditions

Interventions

DRUG

Qing Re Huo Xue (QRHX) granule

Qing Re Huo Xue (QRHX) granule 10g bid for 24 weeks

DRUG

Methotrexate

Oral methotrexate 10 mg per week for 24 weeks.

DRUG

Qing Re Huo Xue (QRHX) granule placebo

Qing Re Huo Xue (QRHX) granule placebo 10g bid for 24 weeks

Sponsors & Collaborators

  • Guang'anmen Hospital of China Academy of Chinese Medical Sciences

    lead OTHER

Principal Investigators

  • Quan Jiang, M.D · Guang' anmen hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-14
Primary Completion
2022-06-28
Completion
2022-06-28

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04170504 on ClinicalTrials.gov